PeptidePedia The community reference

Adverse effects of GLP-1 receptor agonists: difference between revisions

Diff·revision 30 → 31·16:47, 18 Sep 2025

Difference between revision 30 and revision 31 of Adverse effects of GLP-1 receptor agonists. This revision changed no lines of source — the edit was a null or whitespace change.

Revision 30 — 15:58, 1 Sep 2025
GastroparesisGwen (talk)
add the rebound point with the follow-up study it comes from
5,791 bytes ±0
Revision 31 — 16:47, 18 Sep 2025
ThymosinTamsin (talk)
unpipe a link that did not need piping
5,791 bytes ±0
No change to the page source.